Novel MicroRNA-Regulated Transcript Networks Are Associated with Chemotherapy Response in Ovarian Cancer

Danai G Topouza1, Jihoon Choi1, Sean Nesdoly2

  • 1Department of Biomedical and Molecular Sciences, Queen's University, 18 Stuart St., Kingston, ON K7L 3N6, Canada.

Insights

Researchers identified novel microRNA and mRNA networks linked to platinum chemotherapy resistance in high-grade serous ovarian cancer (HGSOC). These findings offer new insights into ovarian cancer treatment resistance mechanisms.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • High-grade serous ovarian cancer (HGSOC) is a leading cause of cancer death.
  • Platinum-based chemotherapy resistance affects 20% of HGSOC patients, highlighting an urgent need to understand underlying mechanisms.

Purpose of the Study:

  • To uncover novel biological mechanisms and transcriptional networks driving chemotherapy resistance in HGSOC.
  • To generate new hypotheses regarding the molecular basis of platinum resistance in ovarian cancer.

Main Methods:

  • Differential expression analysis of mRNA and microRNA sequencing data from The Cancer Genome Atlas (TCGA) HGSOC cohort.
  • Coexpression network analysis to identify key biological pathways and regulatory interactions.
  • Replication of identified network modules in independent ovarian cancer patient cohorts.
  • Integrative analysis of sequencing data with single-nucleotide polymorphisms (SNPs).

Main Results:

  • Identified 21 microRNAs associated with angiogenesis and 196 mRNAs linked to adaptive immunity and translation.
  • Discovered three microRNA networks (lipoprotein transport, oncogenic pathways) and two mRNA networks (ubiquitination, lipid metabolism) associated with chemotherapy response.
  • Validated these network modules across independent cohorts.
  • Revealed potential microRNA and SNP regulation of key mRNA transcripts.

Conclusions:

  • Reported novel transcriptional networks and biological pathways implicated in platinum chemotherapy resistance in HGSOC.
  • Expanded understanding of the molecular effectors and regulators influencing chemotherapy response in ovarian cancer.
  • Findings provide a foundation for improving ovarian cancer management strategies.